Cellectar Biosciences Inc (CLRB)
3.20
-0.10
(-3.03%)
USD |
NASDAQ |
May 20, 12:21
Cellectar Biosciences Gross Profit (Quarterly)
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.0083M |
| December 31, 2009 | 0.0193M |
| September 30, 2009 | 0.0137M |
| June 30, 2009 | 0.0323M |
| March 31, 2009 | 0.031M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Eli Lilly and Co | 7.094B |
| Actinium Pharmaceuticals Inc | -- |
| Bristol-Myers Squibb Co | 8.933B |
| Altimmune Inc | -- |